Drugs and Devices

Potential new treatment for SRI-resistant patients with depression

S-adenosyl methionine (SAMe), a naturally occurring molecule, may be an effective treatment for patients with depression who don’t respond to serotonin reuptake inhibitors (SRIs) according to a study of 73 patients in the American Journal of Psychiatry. Read more here.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares